// company-profile
Keros Therapeutics, Inc.
KROS// activity-summary
Recent insider activity is bullish. Over the last 30 days, 10 insiders purchased shares. Buying was led by GRAY MARY ANN.
// 90-day insight
Over the last 90 days, Keros Therapeutics, Inc. insiders bought $17K across 12 transactions with no open-market sales.
- Most active insider: BIENAIME JEAN JACQUES with 5 transactions totaling $32K.
- Largest single sale: $28K by Knowles Julius on Jun 4, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Keros Therapeutics, Inc. as of 2026-03-31
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | BIENAIME JEAN JACQUES | KROS | Purchase10b5 | 1,000 | $10.19 | $10K |
| Jun 11, 2026 | Newton Charles W. | KROS | Sale10b5 | 550 | $10.04 | $6K |
| Jun 4, 2026 | Knowles Julius | KROS | Sale10b5 | 2,625 | $10.73 | $28K |
| Jun 4, 2026 | Farzan Nima | KROS | Sale10b5 | 2,625 | $10.73 | $28K |
| Jun 4, 2026 | Seth Alpna | KROS | Sale10b5 | 2,625 | $10.72 | $28K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.